MBBS/BSc (Hons 1), Ear, Nose and Throat Principal House Officer, Toowoomba Base Hospital, Toowoomba, Qld.
BAppSc (EXSS), MBBS, MSpMed, FRACS, Visiting Medical Officer, Ear, Nose and Throat Surgeon, Gold Coast University Hospital, Southport, Qld.
Aust J Gen Pract. 2023 Jan-Feb;52(1-2):47-51. doi: 10.31128/AJGP-02-22-6327.
Thyroid cancer diagnoses are increasing in Australia. Increased detection and excellent prognosis of differentiated thyroid cancers has led to a growing cohort of patients undergoing post-treatment survivorship care.
The aim of this article is to provide an overview of the principles and modalities of differentiated thyroid cancer survivorship care in adults and present a framework for follow-up within general practice.
Surveillance for recurrent disease is an important component of survivorship care and involves clinical assessment, biochemical monitoring of serum thyroglobulin and anti-thyroglobulin antibodies and ultrasonography. Thyroid‑ stimulating hormone suppression is frequently used to reduce the risk of recurrence. Clear communication between the patient's thyroid specialists and their general practitioners is important to plan and monitor effective follow-up.
在澳大利亚，甲状腺癌的诊断数量正在增加。分化型甲状腺癌的检出率增加和极佳的预后，导致越来越多的患者需要接受治疗后的生存护理。
本文旨在概述成人分化型甲状腺癌生存护理的原则和方式，并提出在全科实践中进行随访的框架。
复发疾病的监测是生存护理的重要组成部分，包括临床评估、血清甲状腺球蛋白和抗甲状腺球蛋白抗体的生化监测以及超声检查。甲状腺刺激激素抑制常用于降低复发风险。患者的甲状腺专家和全科医生之间进行清晰的沟通对于计划和监测有效的随访非常重要。
